Senior insider sale
Chief Executive Officer at GALECTIN THERAPEUTICS INC — senior position signals high conviction
$38.7K
7.73K shares
What this filing means
SHLEVIN HAROLD H. plans to sell 7.73K shares of GALECTIN THERAPEUTICS INC valued at approximately $38.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/26/2026ACC: 0001628280-26-045766
Officer· Chief Executive Officer
Since Jan 2019
7.73K
Shares to sell
$38.7K
Approx. market value
7.73K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
STOCK OPTION EXERCISE
CASH UPON EXERCISE
1/23/2025
7.73KTotal acquired7.73K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/23/2025 | STOCK OPTION EXERCISE CASH UPON EXERCISE | 7.73K | — |
| Total | 7.73K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
7.73K
Market value
$38.7K
6/26/2026
Total
Units
7.73K
Value
$38.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/26/2026 | 7.73K | $38.7K | NASDAQ | Planned |
| Total | 7.73K | $38.7K | ||